Study for regulation mechanism of IGF1R in the proliferation and metastasis of nasopharyngeal carcinoma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002625

Enrollment

Unknown

Registered

2012-10-17

Start date

2012-10-29

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

test arm:metformin

Control:No intervention

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: male, 18-60 years old, pathological verified nasopharyngeal carcinoma patients.

Exclusion criteria

Exclusion criteria: with diabetes mellitus or Impaired glucose metabolism; contraindication to metformin;severe Cardiopulmonary disease.

Design outcomes

Primary

Measure	Time frame
molecular markers;OR;	—

Countries

China

Contacts

Public ContactXIANG YAN QUN

xiangyq@sysucc.org.cn+86 020-87343770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026